Comparison of T(1) and T(2) Metabolite Relaxation Times in Glioma and Normal Brain at 3T

Overview

Journal J Magn Reson Imaging

Date 2008 Jul 31

PMID 18666155

Citations 39

Authors

Yan Li

Radhika Srinivasan

Helene Ratiney

Ying Lu

Susan M Chang

Sarah J Nelson

Affiliations

Soon will be listed here.

Abstract

Purpose: To measure T(1) and T(2) relaxation times of metabolites in glioma patients at 3T and to investigate how these values influence the observed metabolite levels.

Materials And Methods: A total of 23 patients with gliomas and 10 volunteers were studied with single-voxel two-dimensional (2D) J-resolved point-resolved spectral selection (PRESS) using a 3T MR scanner. Voxels were chosen in normal appearing white matter (WM) and in regions of tumor. The T(1) and T(2) of choline containing compounds (Cho), creatine (Cr), and N-acetyl aspartate (NAA) were estimated.

Results: Metabolite T(1) relaxation values in gliomas were not significantly different from values in normal WM. The T(2) of Cho and Cr were statistically significantly longer for grade 4 gliomas than for normal WM but the T(2) of NAA was similar. These differences were large enough to impact the corrections of metabolite levels for relaxation times with tumor grade in terms of metabolite ratios (P < 0.001).

Conclusion: The differential increase in T(2) for Cho and Cr relative to NAA means that the ratios of Cho/NAA and Cr/NAA are higher in tumor at longer echo times (TEs) relative to values in normal appearing brain. Having this information may be useful in defining the acquisition parameters for optimizing contrast between tumor and normal tissue in MR spectroscopic imaging (MRSI) data, in which limited time is available and only one TE can be used.

Citing Articles

Simultaneous Concentration and T Mapping of Brain Metabolites by Fast Multi-Echo Spectroscopic Imaging.

Rizzo R, Stamatelatou A, Heerschap A, Scheenen T, Kreis R NMR Biomed. 2025; 38(2):e5318.

PMID: 39781896 PMC: 11713224. DOI: 10.1002/nbm.5318.

Concentric Ring Trajectory Sampling With k-Space Reordering Enables Assessment of Tissue-Specific T and T Relaxation for H-Labeled Substrates in the Human Brain at 7 T.

Bader V, Strasser B, Bogner W, Hingerl L, Frese S, Duguid A NMR Biomed. 2024; 38(2):e5311.

PMID: 39702927 PMC: 11659634. DOI: 10.1002/nbm.5311.

Absolute Metabolite Quantification in Individuals with Glioma and Healthy Individuals Using Whole-Brain Three-dimensional MR Spectroscopic and Echo-planar Time-resolved Imaging.

Baboli M, Wang F, Dong Z, Dietrich J, Uhlmann E, Batchelor T Radiology. 2024; 312(3):e232401.

PMID: 39315894 PMC: 11449233. DOI: 10.1148/radiol.232401.

Relaxation-Diffusion Spectrum Imaging for Probing Tissue Microarchitecture.

Wu Y, Liu X, Zhang X, Huynh K, Ahmad S, Yap P Med Image Comput Comput Assist Interv. 2024; 14227:152-162.

PMID: 39184022 PMC: 11340880. DOI: 10.1007/978-3-031-43993-3_15.

Repeatability of Lac+ measurements in healthy human brain at 3 T.

Armbruster R, Wilson N, Elliott M, Liu F, Benyard B, Jacobs P NMR Biomed. 2024; 37(9):e5158.

PMID: 38584133 PMC: 11896080. DOI: 10.1002/nbm.5158.

References

Isobe T, Matsumura A, Anno I, Yoshizawa T, Nagatomo Y, Itai Y . Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging. 2002; 20(4):343-9. DOI: 10.1016/s0730-725x(02)00500-3. View

Kinoshita Y, Yokota A . Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10(1):2-12. DOI: 10.1002/(sici)1099-1492(199701)10:1<2::aid-nbm442>3.0.co;2-n. View

Preul M, Caramanos Z, Collins D, Villemure J, LeBlanc R, Olivier A . Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996; 2(3):323-5. DOI: 10.1038/nm0396-323. View

Howe F, Barton S, Cudlip S, Stubbs M, Saunders D, Murphy M . Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003; 49(2):223-32. DOI: 10.1002/mrm.10367. View

Mates J, Perez-Gomez C, Nunez de Castro I, Asenjo M, Marquez J . Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol. 2002; 34(5):439-58. DOI: 10.1016/s1357-2725(01)00143-1. View

Mlynarik V, Gruber S, Moser E . Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001; 14(5):325-31. DOI: 10.1002/nbm.713. View

Provencher S . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993; 30(6):672-9. DOI: 10.1002/mrm.1910300604. View

Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D . Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain. 2005; 128(Pt 5):1016-25. DOI: 10.1093/brain/awh467. View

Gill S, Thomas D, van Bruggen N, Gadian D, Peden C, Bell J . Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr. 1990; 14(4):497-504. DOI: 10.1097/00004728-199007000-00001. View

10.

Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W . Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med. 2003; 50(6):1296-301. DOI: 10.1002/mrm.10640. View

11.

Tong Z, Yamaki T, Harada K, Houkin K . In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging. 2004; 22(7):1017-24. DOI: 10.1016/j.mri.2004.02.007. View

12.

Takano T, Lin J, Arcuino G, Gao Q, Yang J, Nedergaard M . Glutamate release promotes growth of malignant gliomas. Nat Med. 2001; 7(9):1010-5. DOI: 10.1038/nm0901-1010. View

13.

Fulham M, Bizzi A, Dietz M, Shih H, Raman R, Sobering G . Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology. 1992; 185(3):675-86. DOI: 10.1148/radiology.185.3.1438744. View

14.

Hurd R, Sailasuta N, Srinivasan R, Vigneron D, Pelletier D, Nelson S . Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med. 2004; 51(3):435-40. DOI: 10.1002/mrm.20007. View

15.

Li Y, Osorio J, Ozturk-Isik E, Chen A, Xu D, Crane J . Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. Magn Reson Imaging. 2006; 24(10):1295-302. DOI: 10.1016/j.mri.2006.07.012. View

16.

Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D . Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005; 18(1):1-13. DOI: 10.1002/nbm.895. View

17.

Choi C, Coupland N, Bhardwaj P, Kalra S, Casault C, Reid K . T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med. 2006; 56(5):971-7. DOI: 10.1002/mrm.21055. View

18.

Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M . Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain. Neuroradiology. 2001; 43(5):353-63. DOI: 10.1007/s002340000473. View

19.

Castillo M, Smith J, Kwock L . Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol. 2000; 21(9):1645-9. PMC: 8174883. View

20.

Govindaraju V, Young K, Maudsley A . Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3):129-53. DOI: 10.1002/1099-1492(200005)13:3<129::aid-nbm619>3.0.co;2-v. View